Workflow
Aeglea BioTherapeutics (AGLE) Investor Presentation - Slideshow
SYRESpyre Therapeutics(SYRE)2022-01-10 20:40

Reimagining The Potential Of Human Enzyme Therapeutics Corporate Overview – January 2022 Nasdaq: AGLE Forward Looking Statements This presentation and the accompanying oral presentation contain "forward-looking" statements that are based on our management's beliefs and assumptions and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including information concerning our current and futu ...